Sanofi US News

Over-the-Counter Allergy Brand Now Offers Topical Relief for Itchy, Dry Skin Just in Time for Summer

Game On! Leslie and Sanofi's Chattem Encourage Families to Put Seasonal Allergies Behind Them and Stay Active This Spring

National Patient Spokesperson Melanie Bloom Commemorates Significant Achievements to Raise Awareness of DVT and Potentially Fatal Complication, Pulmonary Embolism

Pathway to Stop Diabetes to provide funding for innovative diabetes researchers

- Sanofi US to Donate Up to $100,000 to Patient Organizations -

- Bettis and Miller, Both at Risk for Anaphylaxis, Join Forces with Sanofi US to Introduce Auvi-Q (Epinephrine Injection, USP) and Serve Up Allergy-Friendly Tips for Big Game Parties -

--LeGoo® proprietary gel technology provides clear surgical field for cardiothoracic and vascular surgeons without trauma to blood vessels--

-- Breakthrough device design talks patients and caregivers through the injection process --

- NBA All-Stars Andre Iguodala and Danny Granger and Seven-Time WNBA All-Star Tamika Catchings to Help Raise Awareness about Diabetes -

-- Product acquisition further strengthens Consumer Healthcare Division of Sanofi US --

- Company’s annual Adopt-a-Family drive delivers essential items to local families in need -

- Registries for All Diseases wins $300k to create crowdsourced cross-disease registry -

Pathway to Stop Diabetes to Provide Funding for Innovative Diabetes Researchers

- New Data Presented at American Society of Hematology Annual Meeting Show Activity Against Disease and Symptom Alleviation -

Response Includes Contribution to Three New Jersey Area Organizations

- Two-Dose Series Given at Regularly Scheduled Pediatric Visits Demonstrates Strong Immune Responses -

Growth Platforms(2) reached over 70% of sales

- QIV is the next evolution of influenza vaccine designed to help protect against influenza B, a significant cause of influenza illness and associated complications across all ages, and especially children -